Yun-Song Yang Selected Research

2,4-diaminohypoxanthine

1/2021

GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun-Song Yang Research Topics

Disease

7	Neoplasms (Cancer) 06/2022 - 01/2020
4	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2020
3	Triple Negative Breast Neoplasms 01/2022 - 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Pathologic Complete Response 01/2020

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2020
1	CeramidesIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	tanespimycin (17AAG)IBA 01/2022
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022
1	isospaglumic acid (NAAGA)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	2,4-diaminohypoxanthineIBA 01/2021
1	5-dehydro-3-deoxy-D-arabino-heptulosonic acid-7-phosphate (DAHP)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	TubulinIBA 01/2021
1	Hormones (Hormone)IBA 11/2020
1	human ERBB2 proteinIBA 11/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Taxoids (Taxanes)IBA 01/2020

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2021
2	Immunotherapy 01/2021 - 01/2021
1	Precision Medicine 01/2022
1	Neoadjuvant Therapy 01/2020